NASDAQ: BVS
Bioventus Inc Stock Ownership - Who owns Bioventus?

Insider buying vs selling

Have Bioventus Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony DadamioSVP General Counsel2025-04-112,958$7.57
$22.39kSell
Mark Leonard SingletonSVP CFO2025-04-113,875$7.57
$29.33kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-04-111,283$7.57
$9.71kSell
Mark Leonard SingletonSVP CFO2025-03-245,479$9.79
$53.64kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-03-171,018$9.75
$9.93kSell
Anthony DadamioSVP General Counsel2025-03-172,615$9.75
$25.50kSell
Mark Leonard SingletonSVP CFO2025-02-186,498$10.19
$66.21kSell
Katrina J. ChurchSVP Chief Compliance Officer2025-02-181,537$10.19
$15.66kSell
Anthony DadamioSVP General Counsel2025-02-184,380$10.19
$44.63kSell
Robert E. ClaypoolePresident and CEO2025-01-1328,786$9.10
$261.95kSell

1 of 2

BVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BVS insiders and whales buy or sell their stock.

BVS Shareholders

What type of owners hold Bioventus Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Smith Nephew PLC20.13%16,534,814$115.25MInsider
Juniper Investment Company LLC16.03%13,168,697$91.79MInsider
Martin P. Sutter15.96%13,106,565$91.35MInsider
Ew Healthcare Partners Acquisition Fund LP15.85%13,021,324$90.76MInsider
Essex Woodlands Management Inc15.85%13,021,324$90.76MInstitution
John A. Bartholdson8.54%7,018,977$48.92MInsider
Juniper Investment Company LLC8.45%6,939,357$48.37MInstitution
Nantahala Capital Management LLC5.02%4,125,650$28.76MInstitution
Spindletop Healthcare Capital LP4.76%3,906,395$27.23MInsider
David J. Parker3.96%3,255,332$22.69MInsider

1 of 3

BVS vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BVS36.99%63.01%Net BuyingNet Selling
AVNS93.74%3.99%Net SellingNet Selling
KIDS43.09%56.91%Net Selling
RXST74.11%25.89%Net BuyingNet Buying
BBNX90.74%9.26%Net BuyingNet Selling

Bioventus Stock Ownership FAQ

Who owns Bioventus?

Bioventus (NASDAQ: BVS) is owned by 57.43% institutional shareholders, 97.82% Bioventus insiders, and 0.00% retail investors. Smith Nephew PLC is the largest individual Bioventus shareholder, owning 16.53M shares representing 20.13% of the company. Smith Nephew PLC's Bioventus shares are currently valued at $113.26M.

If you're new to stock investing, here's how to buy Bioventus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.